Loading...
Docoh

Relay Therapeutics (RLAY)

Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.

Company profile

RLAY stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$34.25
Low target
$13.00
High target
$47.00
Jefferies
Initiated
Underperform
$13.00
6 Jun 22
Goldman Sachs
Maintains
Buy
$42.00
24 May 22
HC Wainwright & Co.
Maintains
Buy
$47.00
10 May 22
JMP Securities
Maintains
Market Outperform
$35.00
9 May 22

Calendar

4 Aug 22
8 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 110.31M 110.31M 110.31M 110.31M 110.31M 110.31M
Cash burn (monthly) 3.9M 12.69M 25.94M 22.44M 19.03M 16.6M
Cash used (since last report) 5.09M 16.57M 33.85M 29.28M 24.84M 21.66M
Cash remaining 105.22M 93.75M 76.47M 81.03M 85.48M 88.65M
Runway (months of cash) 27.0 7.4 2.9 3.6 4.5 5.3

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 Jul 22 Adams Brian Common Stock Sell Dispose S No No 21.27 734 15.61K 62,842
28 Jul 22 Bergstrom Donald A Common Stock Sell Dispose S No No 21.27 1,835 39.03K 89,659
28 Jul 22 Thomas Catinazzo Common Stock Sell Dispose S No No 21.26 734 15.6K 52,218
28 Jul 22 Andy Porter Common Stock Sell Dispose S No No 21.27 452 9.61K 45,871
13F holders Current Prev Q Change
Total holders 138 129 +7.0%
Opened positions 26 19 +36.8%
Closed positions 17 24 -29.2%
Increased positions 43 69 -37.7%
Reduced positions 38 19 +100.0%
13F shares Current Prev Q Change
Total value 3.31B 3.36B -1.5%
Total shares 110.58M 109.4M +1.1%
Total puts 85.2K 94.3K -9.7%
Total calls 82K 6.8K +1105.9%
Total put/call ratio 1.0 13.9 -92.5%
Largest owners Shares Value Change
SB Investment Advisers 27.9M $835.2M 0.0%
FMR 16.24M $486.12M +0.2%
Vanguard 6.22M $186.09M +0.3%
BLK Blackrock 5.97M $178.81M -0.3%
TROW T. Rowe Price 5M $149.64M +20.3%
BVF 4.53M $135.6M +44.7%
Driehaus Capital Management 4.05M $121.24M +0.4%
BLVGF Bellevue 3.92M $117.3M -4.6%
Casdin Capital 3.86M $115.45M 0.0%
JPM JPMorgan Chase & Co. 3.27M $98M -2.8%
Largest transactions Shares Bought/sold Change
BVF 4.53M +1.4M +44.7%
TROW T. Rowe Price 5M +844.38K +20.3%
Norges Bank 0 -820K EXIT
FHI Federated Hermes 0 -600K EXIT
Gilder Gagnon Howe & Co 274.28K -522.46K -65.6%
EcoR1 Capital 2.29M +512.36K +28.8%
Nextech Invest 475.49K +475.49K NEW
Artisan Partners Limited Partnership 304.05K +304.05K NEW
Sessa Capital IM 301.2K +301.2K NEW
BLVGF Bellevue 3.92M -187K -4.6%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Good
New words: CCA, chemically, commodity, cyclin, degrader, ER, estrogen, FGFRi, QD, rationally, slowdown, stability, thirteen, traditional
Removed: assessing, continually, emerge, oncogenic, partially, regional, situation